Design, recruitment, and baseline characteristics of the LENS trial
<p><strong>Background:</strong> Findings from cardiovascular outcome trials suggest that treatment with fenofibrate may reduce the progression of diabetic retinopathy. However, no dedicated large-scale randomised trials have yet investigated this hypothesis.</p> <...
| Päätekijä: | |
|---|---|
| Muut tekijät: | |
| Aineistotyyppi: | Journal article |
| Kieli: | English |
| Julkaistu: |
Wiley
2024
|